Expand to Europe
Our EU platform of services, modular, tailored, and built for biotech with a 1st medicine.
Client Specific EU Hubs:
From initial entry to long-term sustainability in the EU ecosystem.

Pave the Way
Confidently Navigate Your Path to Develop and Register Your First Orphan Product in Europe.

Boost Access
Accelerate Patient Access in Europe - Fast-Track Your Innovation if Eligible.

Scale Up
Build and Grow your European footprint. From Pan-European Strategy to Local Success.

Pave the Way
Confidently Navigate Your Path to Develop and Register Your First Orphan Product in Europe.

Your Goal
Design the optimal regulatory pathway during drug development and achieve key milestones in the registration process.Our Solution
- A dedicated team, who understands the complexities of entering Europe for the first time, to drive progress and keep you on track.
- A clear, customized EU regulatory & development roadmap aligned with your global plan.
- Guidance through scientific advice, PIP, ODD, eCTD submission preparation, and registration milestones.
- Hands-on operational support setup for regulatory readiness and to activate essential EU infrastructure
- Centralized coordination across internal teams and external stakeholders to keep timelines on track

Boost Access
Accelerate Patient Access in Europe. Fast-Track Your Innovation if Eligible.

Your Goal
Maximize your product’s potential with strategic use of EMA accelerated pathways and regulatory/HTA strategy to speed up approvals and access.Our Solution
- A clear assessment of your eligibility for PRIME, CMA,
or other fast-track routes. - A strategy to engage authorities early and effectively.
- Integrated regulatory + HTA planning to streamline approvals and reimbursement.
- Experienced partners to manage submissions, advice procedures, and follow-up

Scale Up
Build and Grow your European footprint. From Pan-European Strategy to Local Success.

Your Goal
Fast-track your market entry in France by acquiring a fully compliant, ready-to-operate Exploitant structure—enabling immediate regulatory alignment without the delays of building from scratch.Our Solution
- A scalable operational footprint and coordination across your target EU markets.
- Local expertise to navigate country-specific requirements with precision to build your EU presence.
- Guidance on setting up a compliant, scalable infrastructure.
- Ongoing support for market optimization and compliance.
Join the Expert Q&A Series
Critical Knowledge. Real Experts. Your Questions.
Get access to concise, high-impact PDFs where our industry veterans distill decades of experience to help you navigate Europe’s complex biotech and pharma landscape.
Each edition focuses on the critical knowledge you need—from regulatory hurdles to post-approval strategy—so you avoid costly missteps and move
forward with clarity.
You’re not just reading—you’re part of the dialogue. Each edition is shaped by questions from our community, and you can submit your own for future
Q&As.
Related articles
Related articles

EMA Marketing Authorization filings 6 common mistakes to avoid
Discover 6 common mistakes that derail EMA marketing authorization filings. Learn how first-time applicants can avoid delays with practical tips and r...

5 Critical Considerations before your first EMA interaction
A practical guide for biopharma companies preparing for their first EMA interaction. Learn 5 critical steps to reduce delays and align with EU regulat...

Expert Q&A - 1st Interactions with European Medicine Agency
Get expert insights on your first interactions with the European Medicines Agency. Learn how to choose the right regulatory pathway, compare timelines...